Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Topical tacalcitol ointment can help improve symptoms of EFFC.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

Lowering the dose of cyclosporin caused hair loss that didn't improve even when the dose was increased again.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.